Kilitch Drugs (India) Ltd Performance
Day's Low
Day's High
₹324.15₹338.0552 Week's Low
52 Week's High
₹247.5₹470
| Returns % | |
| 1 Month Return | -9.76 % |
| 3 Month Return | -10.71 % |
| 1 Year Return | + 26.21 % |
| Market Stats | |
| Previous Close | ₹331.50 |
| Open | ₹338.05 |
| Volume | 4,469.00 |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹533.13Cr |
Kilitch Drugs (India) Ltd Key Statistics
| P/E Ratio | 42.23 |
| PEG Ratio | 127.97 |
| Market Cap | ₹533.13 Cr |
| P/B Ratio | 2.81 |
| EPS | 8.44 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 8.39 |
Kilitch Drugs (India) Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹533.13 Cr | 33.92% | 0.56 | ₹13 Cr | ₹154 Cr | |
| NA | ₹207.23 Cr | 49.33% | 0.79 | ₹7 Cr | ₹339 Cr | |
| NA | ₹10.56 Cr | 219.49% | 0.50 | NA | NA | |
| BUY | ₹6,511.04 Cr | 14.02% | 0.62 | ₹48 Cr | ₹717 Cr | |
| NA | ₹28.64 Cr | 67.38% | 0.50 | NA | NA |
About Kilitch Drugs (India) Ltd
Share Price: ₹325.65 per share as on 21 Oct, 2024 04:01 PM
Market Capitalisation: ₹533.13Cr as of today
Revenue: ₹33.45Cr as on June 2024 (Q2 24)
Net Profit: ₹0.11Cr as on June 2024 (Q2 24)
Listing date: 29 Sep, 2010
Chairperson Name: Mukund P Mehta
| Organisation | Kilitch Drugs (India) Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Kilitch Drugs (India) Ltd
Kilitch Healthcare India Receives Warning Letter from USFDA - 12 Apr, 2024
The US Food and Drug Administration (USFDA) has issued a warning letter to Kilitch Healthcare India for manufacturing lapses, including packing drugs in insanitary conditions at its Maharashtra-based plant. The Navi-Mumbai plant produces finished pharmaceuticals.
Kilitch Healthcare India Receives Warning Letter from USFDA - 11 Apr, 2024
The US Food and Drug Administration (USFDA) has issued a warning letter to Kilitch Healthcare India for significant violations of current good manufacturing practice regulations, including packing drugs in insanitary conditions at its Maharashtra-based plant.
Insights on Kilitch Drugs (India) Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTRetail Holding Unchanged
Retail Investor holdings remained unchanged at 30.77% of holdings in Jun 2024 quarter
- NO EFFECT
Against Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 83.8% return, outperforming this stock by 57.5%
- NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 133.4% return, outperforming this stock by 29.3%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 69.23% of holdings in Jun 2024 quarter
NEGATIVE IMPACTPrice Dip
In the last 1 month, KILITCH stock has moved down by -9.8%
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 45.29 Cr → 36.03 Cr (in ₹), with an average decrease of 20.5% per quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 3.59 Cr → 1.34 Cr (in ₹), with an average decrease of 62.7% per quarter
Kilitch Drugs (India) Ltd Financials
Kilitch Drugs (India) Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 69.23% | 0.00 | |
| Foreign Institutions | 0% | ||
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 30.77% | 0.00 | |
| Others | 0% | 0.00 |
Kilitch Drugs (India) Ltd Key Indicators
Kilitch Drugs (India) Ltd Valuation
Kilitch Drugs (India) Ltd in the last 5 years
Lowest (-986.00x)
July 3, 2019
Today (42.23x)
October 18, 2024
Industry (58.10x)
October 18, 2024
Highest (363.79x)
October 16, 2020
Kilitch Drugs (India) Ltd Earnings and Dividends
Kilitch Drugs (India) Ltd Earnings Results
Kilitch Drugs (India) Ltd’s net profit fell -60.12% since last year same period to ₹1.34Cr in the Q1 2024-2025. On a quarterly growth basis, Kilitch Drugs (India) Ltd has generated -62.67% fall in its net profits since last 3-months.
Read More about Earnings ResultsKilitch Drugs (India) Ltd Dividends May,2019
In the quarter ending March 2019, Kilitch Drugs (India) Ltd has declared dividend of ₹0.50 - translating a dividend yield of 0.15%.
Read More about Dividends
Kilitch Drugs (India) Ltd Technicals Summary
Bearish
Neutral
Bullish
Kilitch Drugs (India) Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Kilitch Drugs (India) Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Kilitch Drugs (India) Ltd shares.
Kilitch Drugs (India) Ltd (KILITCH) share price today is ₹325.65
Kilitch Drugs (India) Ltd is listed on NSE
Kilitch Drugs (India) Ltd is listed on BSE
- Today’s highest price of Kilitch Drugs (India) Ltd is ₹338.05.
- Today’s lowest price of Kilitch Drugs (India) Ltd is ₹324.15.
PE Ratio of Kilitch Drugs (India) Ltd is 42.23
PE ratio = Kilitch Drugs (India) Ltd Market price per share / Kilitch Drugs (India) Ltd Earnings per share
Today’s traded volume of Kilitch Drugs (India) Ltd(KILITCH) is 4,469.00.
Today’s market capitalisation of Kilitch Drugs (India) Ltd(KILITCH) is ₹533.13Cr.
| Kilitch Drugs (India) Ltd(KILITCH | Price |
|---|---|
52 Week High | ₹470 |
52 Week Low | ₹247.5 |
Kilitch Drugs (India) Ltd(KILITCH) share price is ₹325.65. It is down -30.71% from its 52 Week High price of ₹470
Kilitch Drugs (India) Ltd(KILITCH) share price is ₹325.65. It is up 31.58% from its 52 Week Low price of ₹247.5
| Kilitch Drugs (India) Ltd(KILITCH | Returns |
|---|---|
1 Day Returns | -5.85% |
1 Month Returns | -9.76% |
3 Month Returns | -10.71% |
1 Year Returns | 26.21% |